Tumour vasculature immaturity, oxidative damage and systemic inflammation stratify survival of colorectal cancer patients on bevacizumab treatment.
肿瘤血管发育不成熟、氧化损伤和全身炎症是贝伐珠单抗治疗结直肠癌患者生存率的分层因素
期刊:Oncotarget
影响因子:
doi:10.18632/oncotarget.24276
Noonan Sinead A, Morrissey Maria E, Martin Petra, Biniecka Monika, Ã'Meachair Shane, Maguire Aoife, Tosetto Miriam, Nolan Blathnaid, Hyland John, Sheahan Kieran, O'Donoghue Diarmuid, Mulcahy Hugh, Fennelly David, O'Sullivan Jacintha